US equities |
MU $1,029.00 ▼-0.66% NVDA $229.28 ▼-0.52% SPCX $162.57 ▲+1.25% TSLA $382.70 ▲+2.05% AAPL $336.64 ▼-1.11% MSFT $535.07 ▲+2.38% AMZN $262.43 ▲+3.29% META $718.67 ▼-0.31%
FinancialContent

Latest News about #cmeplanet

Recent news which mentions #cmeplanet

2026 AAHFN CME Symposium - Practical Management of Transthyretin Cardiac Amyloidosis
Tickers CME
Tags Amyloidosis Medical United States
From PRLog
2026 AAHFN CME Symposium - Maintaining RAAS Inhibition and Managing Hyperkalemia: Expert Insights into Best HF Patient Care
Tickers CME RAAS
Tags New Jersey AAHFN2026 Education
From PRLog
2025 HFSA CME Symposium - Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Patients with Heart Failure: New Opportunities to Improve Patient Outcomes
Tickers CME
Tags Meded HFSA HFSA2025
From PRLog
2025 HFM Symposium - Optimizing the Management of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Patients with Heart Failure
Tickers CME
Tags Hazlet #cmeplanet Cme
From PRLog
2025 AXS CME Symposium - Best Practices for Managing Hyperkalemia in Patients with Heart Failure and Chronic Kidney Disease
Tickers CME
Tags #kidneycare Axs25 New Jersey
From PRLog
2024 AHA CME Symposium - Managing Hyperkalemia in Heart Failure: Overcoming Roadblocks with Best Practices
Tickers CME
Tags AHA24 Medical United States
From PRLog
2024 NCS CME Symposium - Addressing Challenges: Best Practices for DOAC Reversal in Intracranial Hemorrhage
Tickers CME NCS
Tags Neuro Ncs Meded
From PRLog
2024 HFMC CME Symposium - Managing Worsening Heart Failure with Reduced Ejection Fraction: Strategies for Successful Outcomes
Tickers CME
Tags Medical New Jersey United States
From PRLog
2024 AMCP CME Symposium - Exploring the Impact of Intravenous Iron for Iron Deficiency in Heart Failure
Tickers CME
Tags United States Pharmacy New Jersey
From PRLog
2023 AHA CME Symposium - Translating Clinical Trials to Clinical Practice: Improving HF Outcomes with Intravenous Iron
Tickers CME HF IRON
Tags New Jersey Aha hf
From PRLog